Pertussis Clinical Trials

188 clinical trials for Pertussis across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective — RECRUITING
• Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis — RECRUITING · PHASE1
• A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series — RECRUITING · PHASE2
• 10-year Follow-up After a Single Dose Acellular Pertussis Vaccination — RECRUITING · PHASE4
• Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants — RECRUITING · NA
• Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine — RECRUITING · PHASE1
• A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) — COMPLETED · PHASE1
• A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) — COMPLETED · PHASE2
• A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine — NOT_YET_RECRUITING
• Establishing a Controlled Human Infection Model of Bordetella Pertussis — COMPLETED · PHASE1
• Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old — NOT_YET_RECRUITING · PHASE4
• Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy — ACTIVE_NOT_RECRUITING
• A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) — NOT_YET_RECRUITING · PHASE1
• Safety Monitoring of Boostagen® Vaccine in Thailand — COMPLETED
• Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine — COMPLETED · PHASE1
• Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine — NOT_YET_RECRUITING · PHASE1
• Safety Monitoring of VacPertagen Vaccine in Thailand — COMPLETED
• Maternal Determinants of Infant Immunity to Pertussis — COMPLETED · PHASE4
• Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents — COMPLETED · PHASE3
• Confirmatory Study of BK1310 in Healthy Infants — COMPLETED · PHASE3
• First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine — COMPLETED · PHASE1
• Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women — ACTIVE_NOT_RECRUITING
• Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants — COMPLETED · PHASE2
• Pertussis Immunization During Pregnancy & HIV Infection — COMPLETED
• Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age — NOT_YET_RECRUITING · PHASE2
• Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults — COMPLETED · PHASE2
• Maternal pertussis immunization in Finland, 4 years (MIFI-4Y) — OTHER · PHASE4
• Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control — OTHER
• Maternal Pertussis Wholecell Responses — COMPLETED · PHASE2
• Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy — OTHER
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults — OTHER · PHASE1
• Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS — COMPLETED · PHASE3
• Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults — COMPLETED · PHASE2
• Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States — COMPLETED
• Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series — OTHER · PHASE2
• Pertussis Acellular Vaccine Adjuvanted With TQL1055 — TERMINATED · PHASE1
• Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . — COMPLETED · PHASE1
• Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya — COMPLETED · NA
• Pathogenic Bordetella Rapid Detection — WITHDRAWN
• A PHASE 1 RANDOMIZED, CONTROLLED, OBSERVER-BLINDED, MULTICENTER STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF AN INVESTIGATIONAL ADJUVANTED TETANUS/DIPHTHERIA/PERTUSSIS BOOSTER VACCINE (TDAP-1018) IN ACELLULAR PERTUSSIS VACCINE PRIMED HEALTHY VOLUNTEERS 18 TO 23 YEARS OF AGE — NOT_YET_RECRUITING · PHASE1
• Post Marketing Surveillance for ADACEL™ in South Korea — COMPLETED · PHASE4
• Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose — COMPLETED · PHASE4
• DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants — COMPLETED · PHASE3
• Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines — COMPLETED
• Observational Study Describing the Immune Profile Induced By Pertussis Vaccines — COMPLETED
• Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease — COMPLETED
• DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants — COMPLETED · PHASE3
• Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth — COMPLETED · PHASE3
• Regulatory Post-Marketing Surveillance Study for TETRAXIM™ — COMPLETED · PHASE4
• Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects — COMPLETED · PHASE1

Refine this search